ArticleAnnals of clinical and translational neurology2026
T
Article in Annals of clinical and translational neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveDifferentiating remyelinated from demyelinated lesions in MS remains challenging without histological confirmation. This study introduces the T
methodsThirty individuals with MS (mean age: 47.5 ± 11.5 years) underwent 3 T MRI using 3D gradient-echo qMRI sequences to generate quantitative maps of T
resultsWe found that hyperintense lesions on TPR exhibited significantly higher T
interpretationIn summary, TPR imaging visually differentiates MS lesions into hyper-, hypo-, and iso-intense categories, whereas all lesions appear hyperintense on FLAIR. Hyperintense TPR lesions correspond to increased water and reduced myelin content, as confirmed by quantitative T
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.